Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION (NDC 75987015003) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 6, 2026 , from http://ppman.hank.ai/transparency/procedure/75987015003/by-state?code_type=NDC
“INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION (NDC 75987015003) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/75987015003/by-state?code_type=NDC. Accessed
November 6, 2026 .
“INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION (NDC 75987015003) by State,” HANK Price Transparency ,
accessed November 6, 2026 ,
http://ppman.hank.ai/transparency/procedure/75987015003/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
75987015003 — Inebilizumab-cdon 10 Mg/ml Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$86,701
National median
$68,573 – $129,899
IQR (p25 – p75)
5
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 75987015003 (NDC), with interquartile range
State Median p25 p75
NJ $281,410 $124,352 $511,583
MI $73,578 $59,315 $91,887